AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Infectious Medicine Article
Article Link
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Case Report | Open Access

Pulmonary cavitary disease due to Mycobacterium xenopi

Yousri Ben Abdallaha, Nabil Belfekib, Timothée Klopfensteinc, Souheil Zayetc( )
Pneumology Department, Hôpital Nord Franche-Comté (HNFC), Belfort, France
Internal Medicine Department, Groupe Hospitalier Sud Ile de France, Melun, France
Infectious Diseases Department, Hôpital Nord Franche-Comté (HNFC), Belfort, France
Show Author Information

Abstract

Non-tuberculous mycobacteria are a significant cause of pulmonary infections worldwide and can be clinically challenging. Mycobacterium xenopi (M. xenopi) has a low pathogenicity and usually requires immunosuppression or lung diseases. We describe herein a scarce case of pulmonary cavitary disease attributed to M. xenopi in a 57-year-old Caucasian patient with underlying structural lung disease successfully treated with rifampicin, ethambutol, clarithromycin, and amikacin.

Keywords

Mycobacterium xenopiNon-tuberculous mycobacteriaCOPDPulmonary cavitary disease

References

【1】
【1】
 
 
Crossref Google Scholar
Infectious Medicine
Volume 1 Issue 1,
March 2022
Pages 63-66
DOI: 10.1016/j.imj.2021.11.001

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Cite this Report
Close
Close
Cite this article:
Abdallah YB, Belfeki N, Klopfenstein T, et al. Pulmonary cavitary disease due to Mycobacterium xenopi. Infectious Medicine, 2022, 1(1): 63-66. https://doi.org/10.1016/j.imj.2021.11.001

1420

Views

2

Crossref

2

Web of Science

1

Scopus
Received: 23 June 2021
Revised: 22 September 2021
Accepted: 16 November 2021
Published: 10 January 2022
© The Author(s) 2021. Published by Elsevier Ltd on behalf of Tsinghua University Press.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)